Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (Her2Neu) are the three widely used biomarkers for analysing the prognosis of breast carcinoma. This evidence concerns the gene ESR1 and breast carcinoma.